Literature DB >> 9369895

Changes in measured resting energy expenditure after Roux-en-Y gastric bypass for clinically severe obesity.

L Flancbaum1, P S Choban, L R Bradley, J C Burge.   

Abstract

BACKGROUND: Roux-en-Y gastric bypass (RYGB) results in sustained weight loss and amelioration of comorbid conditions in patients with clinically severe obesity. The mechanism of weight loss after RYGB is not well defined. The objective of this study was to document the changes in measured resting energy expenditure (MREE) over time in patients with clinically severe obesity after RYGB.
METHODS: We prospectively studied MREE in 70 patients (11 male, 59 female; body mass index [BMI], 40 to 80 kg/m2) treated by RYGB. MREE was measured by indirect calorimetry before operation and at 6 weeks and 3, 6, 12, 18, and 24 months after operation. Patients were stratified to hypometabolic ([HM] MREE less than 85% of Harris-Benedict [HB] predicted; n = 22) or normal metabolic rate ([NM] MREE +/- 15% HB predicted; n = 48) before operation; mean BMIs were HM, 53.4 +/- 11.0 kg/m2; NM, 51.4 +/- 9.8 kg/m2; p = not significant. MREE, weight loss, percent excess body weight loss (EWL), and energy intake were determined at each time point.
RESULTS: Overall, MREE was significantly less than HB-predicted REE before operation (90 +/- 28%), but rose to become equal to the HB-predicted REE by 6 weeks (96 +/- 15%) and remained so. When stratified by initial metabolic rate, MREE increased significantly in the HM patients by 6 weeks, from 1329 +/- 604 kcal/day (55% of HB predicted) to 1882 +/- 398 kcal/day (88% of HB predicted) (p < 0.001), and MREE remained normal (2332 +/- 484 kcal/day to 2029 +/- 410 kcal/day) in the NM patients. Percent EWL was similar in both groups at each time. Energy intake was 2603 +/- 982 kcal/day before operation and fell to 815 +/- 196 kcal/day at 3 months, 969 +/- 241 kcal/day at 6 months, 1095 +/- 307 kcal/day at 12 months, 1259 +/- 466 kcal/day at 18 months, and 1373 +/- 620 kcal/day at 24 months, and was similar between the groups at each time point. Percent HB-predicted REE increased significantly after operation despite a significant decrease in energy intake.
CONCLUSIONS: RYGB is associated with significant changes in MREE over time. In NM patients MREE fell over time consistent with weight loss but remained normal, whereas patients who were hypometabolic exhibited increases in MREE toward normal. These changes in MREE occurred despite reduced energy intake comparable to a very low calorie diet. This paradoxical effect on MREE may contribute to the enhanced weight loss associated with RYGB.

Entities:  

Mesh:

Year:  1997        PMID: 9369895     DOI: 10.1016/s0039-6060(97)90336-6

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  39 in total

1.  Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery.

Authors:  Gabrielle Page-Wilson; Sharon L Wardlaw; Alexander G Khandji; Judith Korner
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

Review 2.  Body weight regulation and obesity.

Authors:  Lee M Kaplan
Journal:  J Gastrointest Surg       Date:  2003 May-Jun       Impact factor: 3.452

3.  Energy expenditure before and after Roux-en-Y gastric bypass.

Authors:  Silvia Leite Faria; Orlando Pereira Faria; Cynthia Buffington; Mariane de Almeida Cardeal; Heloisa Rodrigues de Gouvêa
Journal:  Obes Surg       Date:  2012-09       Impact factor: 4.129

Review 4.  Mechanisms underlying weight loss after bariatric surgery.

Authors:  Alexander D Miras; Carel W le Roux
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-09       Impact factor: 46.802

5.  Predicted vs. Actual Resting Energy Expenditure and Activity Coefficients: Post-Gastric Bypass, Lean and Obese Women.

Authors:  Farah A Ramirez-Marrero; Kim L Edens; Michael J Joyner; Timothy B Curry
Journal:  Obes Control Ther       Date:  2014

Review 6.  Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms.

Authors:  Sean Manning; Andrea Pucci; Rachel L Batterham
Journal:  J Clin Invest       Date:  2015-03-02       Impact factor: 14.808

Review 7.  The Role of the Vagal Nucleus Tractus Solitarius in the Therapeutic Effects of Obesity Surgery and Other Interventional Therapies on Type 2 Diabetes.

Authors:  Claudio Blasi
Journal:  Obes Surg       Date:  2016-12       Impact factor: 4.129

Review 8.  Changes in neurohormonal gut peptides following bariatric surgery.

Authors:  C N Ochner; C Gibson; M Shanik; V Goel; A Geliebter
Journal:  Int J Obes (Lond)       Date:  2010-07-13       Impact factor: 5.095

Review 9.  Surgical weight loss: impact on energy expenditure.

Authors:  David Thivel; Katrina Brakonieki; Pascale Duche; Béatrice Morio; Morio Béatrice; Yves Boirie; Boirie Yves; Blandine Laferrère
Journal:  Obes Surg       Date:  2013-02       Impact factor: 4.129

10.  Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss.

Authors:  Adeline Divoux; Joan Tordjman; Danièle Lacasa; Nicolas Veyrie; Danielle Hugol; Abdelhalim Aissat; Arnaud Basdevant; Michèle Guerre-Millo; Christine Poitou; Jean-Daniel Zucker; Pierre Bedossa; Karine Clément
Journal:  Diabetes       Date:  2010-08-16       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.